They sound pretty confident and they seemed to have convinced Nasdaq about what thier plan is.
Novogen Limited (NASDAQ:NVGN) [Trend Analysis] reported that that Nasdaq has permitted that the firm’s definitive plan to attain as well as maintain compliance with the minimum stockholders’ equity rule necessary by Nasdaq.
In turn to facilitate the review, the firm provided Nasdaq by means of a specific plan on how it aims to achieve as well as maintain compliance with the Nasdaq Capital Market listing requirements.
The firm’s compliance plan comprised the completion in November 2014 of an A$1.5 million equity private placements from side to side an offering of ordinary shares and options as well as in December 2014 of a A$5.6 million equity private placements from side to side an offering of ordinary shares and options to US investors.
Novogen Limited (NASDAQ:NVGN) stock hit highest price at $2.65, beginning with a price of $2.35 to the closed at 2.45 by an increase of 4.70% with a day range of $2.30-$2.65. The total market capitalization remained 16.5 Million, total volume of 459707 shares held in the session was surprisingly higher than its average volume of 627.50 shares.
